1.
Clin Pharmacol Ther
; 84(6): 734-40, 2008 Dec.
Article
in English
| MEDLINE
| ID: mdl-18830226
Subject(s)
Anti-HIV Agents/administration & dosage , HIV Infections/drug therapy , Patient Care Planning , Practice Guidelines as Topic , Reverse Transcriptase Inhibitors/administration & dosage , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/drug therapy , Adolescent , Age Factors , Anti-HIV Agents/adverse effects , Anti-Retroviral Agents , Antiretroviral Therapy, Highly Active/adverse effects , Antiretroviral Therapy, Highly Active/methods , Clinical Trials as Topic , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Global Health , HIV Infections/diagnosis , HIV Seropositivity , Humans , Male , Maximum Tolerated Dose , Needs Assessment , Prognosis , Reverse Transcriptase Inhibitors/adverse effects , Risk Assessment , Severity of Illness Index , Treatment Outcome , World Health Organization
2.
Pediatr Emerg Care
; 14(2): 145-7, 1998 Apr.
Article
in English
| MEDLINE
| ID: mdl-9583400
ABSTRACT
A case of albuterol abuse by a pediatric patient with the development of hypokalemia with electrocardiographic changes is presented. The hypokalemic effects of beta2-agonists are discussed in regard to the production of significant cardiac symptoms. Additionally, guidance regarding the evaluation of similar patients presenting in the emergency department is provided.
